Renalytix plc Debt and Equity Securities, Realized Gain (Loss)
Renalytix plc (RNLXY) reported Debt and Equity Securities, Realized Gain (Loss) of $0 for the 9-month period ending 2022-03-31, per its 6-K filed 2022-06-30.
Discontinued › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesRealizedGainLoss · last filed 2022-10-31
- Renalytix plc debt and equity securities, realized gain (loss) for the quarter ending 2022-03-31 was $0.00.
- Renalytix plc debt and equity securities, realized gain (loss) for the quarter ending 2021-06-30 was $0.00.
- Renalytix plc debt and equity securities, realized gain (loss) for the quarter ending 2021-03-31 was $0.00.
| Period end | Debt and Equity Securities, Realized Gain (Loss) 3 month | Debt and Equity Securities, Realized Gain (Loss) 6 month | Debt and Equity Securities, Realized Gain (Loss) 9 month | Debt and Equity Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-03-31 | $0.00 derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30 | $0.00 6-K · filed 2022-06-30 | ||
| 2021-12-31 | $0.00 6-K/A · filed 2022-04-29 | |||
| 2021-06-30 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $18.00K 20-F · filed 2022-10-31 | |
| 2021-03-31 | $0.00 derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30 | $18.00K 6-K · filed 2022-06-30 | ||
| 2020-12-31 | $18.00K 6-K/A · filed 2022-04-29 | |||
| 2020-06-30 | $128.00K 20-F · filed 2022-10-31 | |||
| 2019-06-30 | $24.00K 20-F/A · filed 2022-08-01 |